Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Podcasts

IBD logo
Podcast
IBD Drive Time: Importance of Diet in the Management of Crohn's Disease
05/25/2023
In the third episode of IBD Drive Time, host Raymond Cross, MD, discusses research into how diet can alleviate symptoms—or worsen disease—among patients with Crohn's disease with Dr James Lewis, who conducted the DINE-CD study.
In the third episode of IBD Drive Time, host Raymond Cross, MD, discusses research into how diet can alleviate symptoms—or worsen disease—among patients with Crohn's disease with Dr James Lewis, who conducted the DINE-CD study.
In the third episode of IBD...
05/25/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive Time Logo
Podcast
IBD Drive Time: Parambir Dulai, MD, on the Role of Biomarkers in IBD
05/17/2023
In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk to Dr Parambir Dulai about abstracts from the ECCO ’23 Congress on the role of biomarkers in the clinical care and research for inflammatory bowel disease.
In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk to Dr Parambir Dulai about abstracts from the ECCO ’23 Congress on the role of biomarkers in the clinical care and research for inflammatory bowel disease.
In this episode of IBD Drive...
05/17/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Jessica Salwen-Deremer
Podcast
Jessica Salwen-Deremer, PhD, on Insomnia in IBD
05/10/2023
Dr Salwen-Deremer discusses some findings of her research into insomnia and sleep disturbance in inflammatory bowel disease, and how cognitive behavioral therapy can help.
Dr Salwen-Deremer discusses some findings of her research into insomnia and sleep disturbance in inflammatory bowel disease, and how cognitive behavioral therapy can help.
Dr Salwen-Deremer discusses some...
05/10/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Ed Barnes, MD, on Novel Therapeutics
05/05/2023
Dr Barnes reviews key abstracts from ECCO 2023 on novel therapeutics for inflammatory bowel disease with hosts Drs Raymond Cross and Millie Long.
Dr Barnes reviews key abstracts from ECCO 2023 on novel therapeutics for inflammatory bowel disease with hosts Drs Raymond Cross and Millie Long.
Dr Barnes reviews key abstracts...
05/05/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive Time Logo
Podcasts
Sara Horst, MD, on Real World Effectiveness and Safety of Ozanimod in IBD
04/19/2023
In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk to Dr Sara Horst about abstracts from the ECCO ’23 Congress on how best to utilize ozanimod to achieve optimum outcomes in inflammatory bowel disease.
In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk to Dr Sara Horst about abstracts from the ECCO ’23 Congress on how best to utilize ozanimod to achieve optimum outcomes in inflammatory bowel disease.
In this episode of IBD Drive...
04/19/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Noa Cleveland
Podcast
Noa Krugliak Cleveland, MD, on Intestinal Ultrasound in IBD Care
04/17/2023
Dr Cleveland, from the University of Chicago, reviews the use of intestinal ultrasound for the monitoring of inflammatory bowel disease and the significant advantages of this noninvasive, point-of-care technology for patients and clinicians...
Dr Cleveland, from the University of Chicago, reviews the use of intestinal ultrasound for the monitoring of inflammatory bowel disease and the significant advantages of this noninvasive, point-of-care technology for patients and clinicians...
Dr Cleveland, from the...
04/17/2023
Advances in Inflammatory Bowel Disease Network
Raymond Cross, MD
Conference Coverage
Raymond Cross, MD, on S1Ps for Treatment of IBD
04/14/2023
S1Ps may work best for patients with moderate to more moderate-severe range of ulcerative colitis in the outpatient setting, particularly those earlier in their treatment journey, Dr Raymond Cross said during his presentation at the AIBD...
S1Ps may work best for patients with moderate to more moderate-severe range of ulcerative colitis in the outpatient setting, particularly those earlier in their treatment journey, Dr Raymond Cross said during his presentation at the AIBD...
S1Ps may work best for patients...
04/14/2023
Advances in Inflammatory Bowel Disease Network
Christina Ha, MD
Conference Coverage
Christina Ha, MD: Biosimilars Are Here To Stay
04/14/2023
When used correctly and in a timely manner, biosimilars may increase access to important medications, such as the anti-tumor necrosis factor inhibitors for the treatment of IBD, Christina Ha, MD, explained at the AIBD regional meeting.
When used correctly and in a timely manner, biosimilars may increase access to important medications, such as the anti-tumor necrosis factor inhibitors for the treatment of IBD, Christina Ha, MD, explained at the AIBD regional meeting.
When used correctly and in a...
04/14/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Tom Wallach
Podcast
Thomas Wallach, MD, and Janet Rosenbaum, PhD, on Pediatric IBD Trends During the Pandemic
04/11/2023
Drs Wallach and Rosenbaum discuss their study into the trends of IBD incidence among children in New York City during the COVID-19 pandemic, and their surprising findings.
Drs Wallach and Rosenbaum discuss their study into the trends of IBD incidence among children in New York City during the COVID-19 pandemic, and their surprising findings.
Drs Wallach and Rosenbaum...
04/11/2023
Advances in Inflammatory Bowel Disease Network
Adam Faye, MD
Podcast
Adam Faye, MD, Reviews Research on the Association Between Antibiotic Exposure and IBD
04/10/2023
Dr Adam Faye elaborates on how antibiotic exposure puts adults aged 40 years and older at an increased risk for developing inflammatory bowel disease.
Dr Adam Faye elaborates on how antibiotic exposure puts adults aged 40 years and older at an increased risk for developing inflammatory bowel disease.
Dr Adam Faye elaborates on how...
04/10/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
News
Assessing Transmural Healing and Response in Patients with Crohn's Disease
11/11/2024
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score...
11/11/2024
Advances in Inflammatory Bowel Disease Network
News
MRE or IUS for Crohn’s Disease Imaging?
11/06/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
11/06/2024
Advances in Inflammatory Bowel Disease Network
News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use